Tag: heart failure
First patient enrolled in trial of Cysoni temporary pacing technology
Ceryx Medical has announced that the first patient has been enrolled in the RSA-Pace multicentre study at Waikato Hospital in Hamilton, New Zealand evaluating...
Abbott initiates TEAM-HF trial to improve outcomes in advanced heart failure...
Abbott has announced a new, “first-of-its-kind” clinical trial designed to improve outcomes in patients with worsening heart failure who could benefit from advanced therapy...
Trial approved for new pacemaker aiming to boost recovery in heart...
Ceryx Medical has announced the approval of a trial evaluating Cysoni-XT—a new temporary cardiac pacemaker aiming to boost recovery in heart failure.
The UK Medicines...
RSA-pace study of Cysoni-XT temporary pacing system granted approval
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ceryx Medical’s clinical trial authorisation application for the pilot respiratory sinus arrhythmia (RSA)-pace...
ACC 2024: Interatrial shunt fails to meet primary endpoint in RELIEVE-HF...
Patients with heart failure who had an interatrial shunt inserted between the left and right atria did not see any significant benefits overall compared...
Endotronix submits premarket approval application to US FDA for Cordella pulmonary...
Endotronix has submitted a premarket approval (PMA) application for its Cordella pulmonary artery (PA) sensor system to the US Food and Drug Administration (FDA).
Cordella...
BioCardia announces FDA review completion of ongoing cell therapy for heart...
BioCardia, a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, has announced that the US Food and Drug...
Impulse Dynamics announces first implantation of combined CCM and ICD device
Impulse Dynamics has today announced the completion of the first implantation for the INTEGRA-D clinical trial, designed to evaluate the safety and efficacy of...
Smart watches could predict higher risk of heart failure and arrhythmia
Wearable devices such as smart watches could be used to detect a higher risk of developing heart failure and irregular heart rhythms in later...
Remote monitoring improves survival in heart failure patients analysis finds
Abbott has today announced new data that found monitoring patients remotely with haemodynamic pressure sensing technology, such as with its CardioMEMS HF System, can...
Analysis of NIS database shows racial disparities in atrial fibrillation outcomes...
Using data from a large and “nationally representative” sample of the US population, a recent study is the first—the authors posit—to demonstrate racial differences...
BioVentrix receives FDA expanded access program approval for ischemic heart failure...
BioVentrix, a privately held medical device company focused on the development of less invasive therapies to directly treat the dilated left ventricle and reverse...
UK regulator approves dapagliflozin for use in heart failure across the...
AstraZeneca has today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a licence extension for dapagliflozin (Forxiga) in Great Britain...
Catheter ablation shown to reduce mortality and hospitalisation in patients with...
An analysis of randomised controlled trials (RCTs) has found catheter ablation reduces mortality and heart failure hospitalisations in patients with atrial fibrillation (AF) and...
CVRx launches new version of neuromodulation device intended to treat heart...
CVRx—the developer of the “world’s first” US Food and Drug Administration (FDA)-approved neuromodulation device to treat the symptoms of heart failure—has launched its new...
Abbott’s CardioMEMS HF system receives FDA approval for use in earlier-stage...
Abbott has announced that the US Food and Drug Administration (FDA) has approved an expanded indication for the company’s CardioMEMS HF system to support...
Ceryx Medical launches Cysoni bionic device for respiratory sinus arrhythmia
A collaboration between Ceryx Medical Limited and the scientists at the Auckland Bioengineering Institute (ABI) and the Universities of Bath and Bristol, have developed...
US physicians “among nation’s first” to implant neurostimulator technology for advanced...
Doctors at St David's Medical Center in Austin, USA recently implanted a new neurostimulator technology in patients to help treat advanced heart failure—and are...
Smartphone app can identify lung congestion in heart failure patients
Voice analysis by a smartphone app can identify lung congestion in heart failure patients, allowing early intervention before their condition deteriorates, a study presented...
ESC to stream the latest science in heart failure
The European Society of Cardiology (ESC) has announced that the HFA Discoveries online event will be running six days of live sessions from 5...
Impulse Dynamics appoints medical director to leadership team
Impulse Dynamics, developer of cardiac contractility modulation (CCM) therapy delivered by the Optimizer Smart System, has announced the appointment of Ishu Rao as medical...
Wearable sensor analytics platform predicts worsening heart failure prior to hospitalisation
Wearing an adhesive patch sensor that streams data to an analytical platform can accurately predict worsening heart failure (HF) and the need for hospitalisation...
US FDA approves Farxiga for reduction in risk of heart failure...
The US Food and Drug Administration (FDA) has approved Farxiga (dapaglifozin, AstraZeneca) to reduce the risk of hospitalisation for heart failure in adults with...
Cardiac magnetic resonance safe and effective at measuring the contraction response...
Researchers have used cardiac magnetic resonance (CMR) imaging for the first time to demonstrate the mechanistic improvements in cardiac contractility consequent to cardiac resynchronisation...
FDA grants Fast-Track designation to develop heart failure drug
The US Food and Drug Administration (FDA) has granted Fast Track designation for the development of dapagliflozin (Farixga, AstraZeneca) to reduce the risk of...
First patient enrolled in European study of AccuCinch ventricular repair system
The first patient has been enrolled in the CorCinch EU study, which is a European multicentre clinical evaluation of the AccuCinch ventricular repair system...
Primary ICD therapy for patients with ischaemic cardiomyopathy in NYHA class...
Primary implantable cardioverter-defibrillator (ICD) implantation may have an incremental benefit for patients who have ischaemic cardiomyopathy without heart failure symptoms. The findings, published in...
New Australian research and development partnership aims to innovate heart failure...
Biotronik, the University of Newcastle (Callaghan, Australia) and the Hunter New England Local Health District (HNE LHD) have partnered to shape a heart failure care model. To...
First trial of in-heart micro device for left atrial pressure monitoring...
Vectorious Medical Technologies has announced the initiation of the VECTOR-HF first-in-human (FIH) clinical trial, and the successful first “in-human” implantation of the V-LAPTM monitoring...
Positive 12-month data presented for CardiAMP Cell Therapy System for heart...
Positive 12-month data have been presented for the roll-in cohort of the pivotal CardiAMP Heart Failure Trial studying the investigational CardiAMP Cell Therapy System...
LivaNova launches international pivotal study evaluating use of autonomic regulation therapy...
LivaNova has announced the first successful implantation of the Vitaria system in a patient enrolled in the Autonomic regulation therapy to enhance myocardial function...
Clinical trial to evaluate ECG belt for optimising heart failure therapy...
Medtronic has announced the first enrolments in a new clinical trial evaluating the ECG (electrocardiography) Belt Research System (ECG Belt) as a diagnostic tool...
HeartWare HVAD system receives US FDA approval
Medtronic has received United States Food and Drug Administration (FDA) approval for a less-invasive implant approach of its HVAD System, a left ventricular assist...
Socioeconomic status and geographic region affect patient access to ICDs in...
There is a disparity between indications for and utilisation of implantable cardioverter defibrillators (ICDs) in Asian patients with heart failure, a recent study finds....
Nearly 25% of chronic ischaemic heart disease patients dead or hospitalised...
Nearly a quarter of patients with chronic ischaemic cardiovascular disease are dead or hospitalised within six months, reports a European Society of Cardiology (ESC) study...
Confirm Rx ICM: Convenient. Connected. Continuous.
This video has been sponsored by Abbott.
The Confirm Rx implantable cardiac monitor (ICM) is the world’s first and only insertable cardiac monitor that combines...
Cardiac contractility modulation device approved in China
The Optimizer system developed by Impulse Dynamics has received approval from the China Food and Drug Administration (CFDA). The Optimizer is an implantable cardiac...
US$50 million raised for SOLVE-CRT study on wireless CRT technology
EBR Systems has raised US$50 million to conduct the global SOLVE-CRT (stimulation of the left ventricle endocardially) study. SOLVE-CRT is a pivotal clinical trial intended to establish safety...
Catheter ablation lowers mortality in atrial fibrillation patients with heart failure
Catheter ablation of atrial fibrillation significantly reduces mortality and hospitalisation in atrial fibrillation patients with heart failure in comparison with conventional treatment, data from...
Abbott’s Full MagLev HeartMate 3 LVAD receives FDA approval
The FDA has approved the Full MagLev HeartMate 3 (Abbott) left ventricular assist device for use in heart failure patients in need of short-term...
EHRA Inventors Award ideas focus on cardiac remote monitoring and CRT...
For the second-year running, the European Heart Rhythm Association (EHRA) held the EHRA Inventors Award competition at EHRA-EUROPACE CARDIOSTIM (18‒21 June, Vienna, Austria), a...
CE mark granted to Medtronic for Attain Stability Quad MRI SureScan...
Medtronic has received CE mark for the Attain Stability Quad MRI SureScan left heart lead. The device offers active-fixation technology, designed for precise lead...
Heart failure patient and clinician risk perceptions differ drastically
Physicians identified a majority of patients with advanced heart failure as at high risk for transplant, left ventricular assist device (LVAD) or death while...
European Commission grants marketing authorisation to Vifor for patiromer hyperkalaemia treatment
The European Commission has granted marketing authorisation for sodium-free potassium binder, patiromer (Valtessa; Vifor Fresenius Medical Care Renal Pharma, Vifor UK), for the treatment...
Gaining a few pounds may increase long-term heart failure risk
Gaining even a little weight over time may alter the structure and function of heart muscle, affecting long-term risk of heart failure, according to...
Late-breaking trials identify early onset of heart failure and lack of...
For the first time this year, late-breaking clinical trials session were held at the Asian Pacific Society of Cardiology (APSC) Congress, to highlight world-class...
The Sound Doctor releases 40 heart failure films for patients
The Sound Doctor, a UK-based provider of health-related film and audio content for patients, has announced a series of 40 films on heart failure.
The...
CRT optimisation: Why a sensor-based strategy may be the optimal solution
This video has been sponsored by LivaNova.
Over the past two decades there have been several optimisation strategies, whether they are echo-guided or EKG-guided, aimed...
Unemployment associated with 50% higher risk of death in heart failure...
Unemployment is associated with a 50% higher risk of death in patients with heart failure, according to research presented at Heart Failure 2017 and...
Physical activity may ward off heart damage
Physical activity can lower the risk of heart damage in middle-aged and older adults and reduce the levels of heart damage in people who...
ACC 2017: More hospitalisations and deaths for US heart failure patients...
Patients with heart failure in the USA are more likely to be hospitalised and more likely to die during the colder winter months, according...
Increased physical activity, lower BMI may lower heart failure risk
While lifestyle patterns, including physical activity and body mass index (BMI), are associated with overall heart failure risk, they are more strongly associated with...
Cardiac resynchronisation therapy upgrade is less favourable than de novo implantations
Results from a large multicentre observational study have shown that patients undergoing cardiac resynchronisation therapy (CRT) upgrade had worse clinical response and long-term survival...
Flu, pneumonia vaccines may improve health of heart failure patients
Flu and pneumonia vaccines may improve the quality of life and outcomes of heart failure patients by providing cost-effective protection against life-threatening respiratory infections,...
Biotronik launches a new series of Ilivia CRT devices
Biotronik has announced the launch of a new series of cardiac resynchronisation therapy (CRT) devices with several functionalities that allow physicians to offer an...
Latest statistics show heart failure on the rise
The number of adults living with heart failure increased from about 5.7 million (2009-2012) to about 6.5 million (2011-2014), according to the American Heart...
Educational Supplement ‒ St. Jude Medical: Tackling heart failure with innovative...
This educational supplement is only available in countries outside the USA.
This educational supplement contains highlights of the 5th edition of The Future of Heart...
Transcatheter atrial shunt benefits persist through one year in treatment of...
Twelve-month results of the REDUCE LAP HF (Reduce elevated left atrial pressure in patients with heart failure) trial have shown both continued device patency...
Christian Butter wins best abstract for SELECT-LV final trial results at...
Christian Butter (Heart Center Brandenburg, Bernau bei Berlin, Germany) was awarded best abstract at the XVII International Symposium on Progress in Clinical Pacing (29...
Medtronic receives CE mark for less-invasive HVAD implant procedure
Medtronic’s HVAD system left ventricular assist device (LVAD) has received CE mark for a less-invasive implant procedure in patients with advanced heart failure. The...
CASE REPORT: WiSE CRT technology ‒ a feasible and effective alternative...
This case report has been written by Timothy Betts (consultant cardiologist and electrophysiologist, Oxford University Hospitals NHS Foundation Trust, Oxford, UK) and has been sponsored by...
Insights into current heart failure management
Piotr Ponikowski (Centre for Heart Disease, Clinical Military Hospital, Wroclaw, Poland), chairperson of the 2016 European Society of Cardiology (ESC) Guidelines for the diagnosis...
AHA 2016: HeartMate 3 LVAS improves clinical outcomes compared with HeartMate...
A prespecified primary analysis of the MOMENTUM 3 US IDE clinical study has indicated improvement in clinical outcomes for advanced heart failure patients implanted...
AHA 2016: Multisensor algorithm may help predict worsening heart failure
Results from the MultiSENSE study have demonstrated that a new multisensor algorithm, the HeartLogic Heart Failure Diagnostic Service (Boston Scientific), provides a timely alert...
AHA 2016: Elizabeth M McNally wins AHA prize for research into...
The American Heart Association (AHA) awarded its Basic Research Prize for 2016 to Elizabeth M McNally (Chicago, USA) for “Ground-breaking investigations of novel genetic...
AHA 2016: Combination of drug therapy and left ventricular assist device...
More than a third of advanced heart failure patients treated with a left ventricular assist device (LVAD) and intensive drug therapy have recovered their heart function enough...
Biotronik launches Inventra ICD for heart failure patients with higher defibrillation...
Biotronik has announced the US launch of Inventra HF-T, an implantable cardioverter defibrillator (ICD) that delivers “ultra-high” energy with 42 joules (J) on the...
Quadra Allure MP CRT-P gets CE mark approval for MRI labeling
St Jude Medical has announced CE mark approval for magnetic resonance (MR) conditional labeling for the company’s Quadra Allure MP cardiac resynchronisation therapy pacemaker (CRT-P).
The...
Painkillers linked to increased risk of heart failure
Commonly used prescribed painkillers for treating pain and inflammation are associated with an increased risk of hospital admission for heart failure, finds a study...
ESC 2016: Remote monitoring for heart failure may not improve clinical...
Two randomised clinical trials presented at a Hot Line session of the European Society of Cardiology Congress (ESC; 27‒31 August, Rome, Italy) have shown...
EBR Systems receives FDA approval to begin IDE study of its...
EBR Systems has announced the US Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) for its WiSE (Wireless Stimulation Endocardially) technology for cardiac...
ESC 2016: Rethink of ICD implantation in non-ischaemic heart failure may...
Implantable cardioverter-defibrillators (ICDs) do not improve overall long-term survival compared to medical treatment in patients with non-ischaemic systolic heart failure, according to results of...
New alliance for heart failure calls for improved care for condition
A coalition of charities, patient groups, professional bodies and healthcare companies with an interest in heart failure has been established to raise the profile...
Cardiac resynchronisation therapy with SonR automated feature helps to reduce hospitalisation...
Results from the RESPOND-CRT trial have shown a 35% risk reduction in hospitalisation at two years for heart failure patients implanted with cardiac resynchronisation...
Insights into genetically-targeted prevention of atrial fibrillation in heart failure patients
The current need for new preventative therapies of atrial fibrillation in chronic heart failure patients—with fewer side effects than currently available treatment strategies—has led...
Many drugs can cause or worsen heart failure, American Heart Association...
Commonly used medications and nutritional supplements may cause or worsen heart failure, according to the first scientific statement from the American Heart Association to...
Wireless CRT has the potential to improve response in heart failure...
The world’s only wireless endocardial pacing system for cardiac resynchronisation therapy (CRT)—WiSE (Wireless Stimulation of the Endocardium) CRT System (EBR Systems)—is showing promise treating...